Brain, Vol. 125, No. 12, 2591-2625,
December 2002
© 2002 Oxford University Press
Review Article |
Peripheral neuropathies and anti-glycolipid antibodies
1 Department of Neurology, Institute of Neurological Sciences, Southern General Hospital, Glasgow, UK and 2 Department of Neurology, Dokkyo University School of Medicine, Tochigi, Japan
Correspondence to: H. J. Willison, University Department of Neurology, Institute of Neurological Sciences, Southern General Hospital, Glasgow G51 4TF, UK E-mail: h.j.willison{at}udcf.gla.ac.uk
This review charts the progress of anti-glycolipid antibodies in neuropathy, from their original discovery 20 years ago in immunoglobulin M paraproteinaemic neuropathy through to current discoveries mapping their relationship to subtypes of Guillain–Barré syndrome. Antibodies to >20 different glycolipids have now been associated with a wide range of clinically identifiable acute and chronic neuropathy syndromes. Particular progress has been achieved in understanding the link between acute motor axonal neuropathy and antibodies to GM1, GD1a, GM1b and GalNAc-GD1a, and between the cranial, bulbar and sensory variants of GBS and antibodies to the disialylated gangliosides GQ1b, GT1a, GD1b and GD3. In addition to clinical and serological studies, the origins and measurement of anti-glycolipid antibodies and their relationships to similar carbohydrate structures on infectious organisms, particularly Campylobacter jejuni, are discussed in the context of a molecular mimicry hypothesis. The structure and nomenclature of relevant glycolipids are outlined, along with information on their localization in nerve, and the influence this has on clinical phenotypes. Major advances have been made in animal modelling of anti-glycolipid antibody-associated diseases, both in vitro and in vivo. This has advanced our understanding of the role of anti-GQ1b antibodies in Miller Fisher syndrome with particular respect to the motor nerve terminal as a potential site of injury, and led to the creation of rabbit models of anti-GD1b and anti-GM1 antibody-mediated sensory and motor neuropathy, respectively. With such information in place, it will now be possible to determine the precise mechanisms by which antibodies injure the different compartments of peripheral nerve and establish how a range of immunomodulating therapies, including current treatments, exert their therapeutic effects. Despite these very significant advances, considerable gaps in our knowledge persist, and it is likely that other pathogenic pathways operate in inflammatory neuropathy that are unrelated to glycolipid antibodies, although these are outside the scope of this review.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Kaida, K. Kamakura, G. Ogawa, M. Ueda, K. Motoyoshi, M. Arita, and S. Kusunoki GD1b-specific antibody induces ataxia in Guillain-Barre syndrome Neurology, July 15, 2008; 71(3): 196 - 201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. H. H. Lopez, G. Zhang, M. A. Bianchet, R. L. Schnaar, and K. A. Sheikh Structural requirements of anti-GD1a antibodies determine their target specificity Brain, July 1, 2008; 131(7): 1926 - 1939. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Williams, A. Wood, E.-J. Williams, Y. Gao, M. L. Mercado, A. Katz, D. Joseph-McCarthy, B. Bates, H.-P. Ling, A. Aulabaugh, et al. Ganglioside Inhibition of Neurite Outgrowth Requires Nogo Receptor Function: IDENTIFICATION OF INTERACTION SITES AND DEVELOPMENT OF NOVEL ANTAGONISTS J. Biol. Chem., June 13, 2008; 283(24): 16641 - 16652. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. WILLISON and J. J. PLOMP Anti-ganglioside Antibodies and the Presynaptic Motor Nerve Terminal Ann. N.Y. Acad. Sci., June 1, 2008; 1132(1): 114 - 123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Makowska, J Pritchard, L Sanvito, N Gregson, M Peakman, A Hayday, and R Hughes Immune responses to myelin proteins in Guillain-Barre syndrome J. Neurol. Neurosurg. Psychiatry, June 1, 2008; 79(6): 664 - 671. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Hatzifilippou, E. Koutsouraki, T. Banaki, M. Traka, V. G. Costa, and S. J. Baloyannis Antibodies Against GM1 in Demented Patients American Journal of Alzheimer's Disease and Other Dementias, June 1, 2008; 23(3): 274 - 279. [Abstract] [PDF]
|
|
|
|
|
|
H. C. Lehmann and H.-P. Hartung Complementing the therapeutic armamentarium for Miller Fisher Syndrome and related immune neuropathies Brain, May 1, 2008; 131(5): 1168 - 1170. [Full Text] [PDF]
|
|
|
|
|
|
S D Arbogast, S Khanna, D W Koontz, R L Tomsak, B Katirji, and R J Leigh Chronic ataxic neuropathy mimicking dorsal midbrain syndrome J. Neurol. Neurosurg. Psychiatry, November 1, 2007; 78(11): 1276 - 1277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-M. LEGER, S. VARGAS, and I. LIEVENS Efficacy of Intravenous Immunoglobulin in Multifocal Motor Neuropathy Ann. N.Y. Acad. Sci., September 1, 2007; 1110(1): 248 - 255. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. C. Hughes, A. V. Swan, J.-C. Raphael, D. Annane, R. van Koningsveld, and P. A. van Doorn Immunotherapy for Guillain-Barre syndrome: a systematic review Brain, September 1, 2007; 130(9): 2245 - 2257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. CONRAD, H. SCHNEIDER, T. ZIEMSSEN, T. TALASKA, D. REINHOLD, R.-L. HUMBEL, and D. ROGGENBUCK A New Line Immunoassay for the Multiparametric Detection of Antiganglioside Autoantibodies in Patients with Autoimmune Peripheral Neuropathies Ann. N.Y. Acad. Sci., August 1, 2007; 1109(1): 256 - 264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Piepers, R. Van den Berg-Vos, W-L. Van der Pol, H. Franssen, J. Wokke, and L. Van den Berg Mycophenolate mofetil as adjunctive therapy for MMN patients: a randomized, controlled trial Brain, August 1, 2007; 130(8): 2004 - 2010. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Fusco, G. Bertani, A. Scarano, and E. D. Giustina Acute Ophthalmoparesis Associated With Anti-GM1, Anti-GD1a, and Anti-GD1b Antibodies After Enterovirus Infection in a 6-Year-Old Girl J Child Neurol, April 1, 2007; 22(4): 432 - 434. [Abstract] [PDF]
|
|
|
|
 |
|
 K. Townson, J. Boffey, D. Nicholl, J. Veitch, D. Bundle, P. Zhang, E. Samain, T. Antoine, A. Bernardi, D. Arosio, et al. Solid phase immunoadsorption for therapeutic and analytical studies on neuropathy-associated anti-GM1 antibodies Glycobiology, March 1, 2007; 17(3): 294 - 303. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. C. Lehmann, P. H. H. Lopez, G. Zhang, T. Ngyuen, J. Zhang, B. C. Kieseier, S. Mori, and K. A. Sheikh Passive Immunization with Anti-Ganglioside Antibodies Directly Inhibits Axon Regeneration in an Animal Model J. Neurosci., January 3, 2007; 27(1): 27 - 34. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Schessl, M Koga, K Funakoshi, J Kirschner, W Muellges, A Weishaupt, R Gold, and R Korinthenberg Prospective study on anti-ganglioside antibodies in childhood Guillain-Barre syndrome Arch. Dis. Child., January 1, 2007; 92(1): 48 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Yu, S. Usuki, and T. Ariga Ganglioside Molecular Mimicry and Its Pathological Roles in Guillain-Barre Syndrome and Related Diseases Infect. Immun., December 1, 2006; 74(12): 6517 - 6527. [Full Text] [PDF]
|
|
|
|
|
|
E. Delmont, J. P. Azulay, R. Giorgi, S. Attarian, A. Verschueren, D. Uzenot, and J. Pouget Multifocal motor neuropathy with and without conduction block: a single entity? Neurology, August 22, 2006; 67(4): 592 - 596. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. C. Lehmann, H.-P. Hartung, G. R. Hetzel, O. Stuve, and B. C. Kieseier Plasma Exchange in Neuroimmunological Disorders: Part 2. Treatment of Neuromuscular Disorders. Arch Neurol, August 1, 2006; 63(8): 1066 - 1071. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Pritchard What's new in Guillain-Barre syndrome? Practical Neurology, August 1, 2006; 6(4): 208 - 217. [Full Text] [PDF]
|
|
|
|
|
|
H. Nodera, H. Bostock, Y. Izumi, K. Nakamura, R. Urushihara, T. Sakamoto, N. Murase, H. Shimazu, S. Kusunoki, and R. Kaji Activity-dependent conduction block in multifocal motor neuropathy: magnetic fatigue test. Neurology, July 25, 2006; 67(2): 280 - 287. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Schmidt-Ott, H. Schmidt, S. Feldmann, F. Brass, B. Krone, and U. Gross Improved Serological Diagnosis Stresses the Major Role of Campylobacter jejuni in Triggering Guillain-Barre Syndrome. Clin. Vaccine Immunol., July 1, 2006; 13(7): 779 - 783. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Avril, E. R. Wagner, H. J. Willison, and P. R. Crocker Sialic Acid-Binding Immunoglobulin-Like Lectin 7 Mediates Selective Recognition of Sialylated Glycans Expressed on Campylobacter jejuni Lipooligosaccharides Infect. Immun., July 1, 2006; 74(7): 4133 - 4141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N Dotan, R. Altstock, M Schwarz, and A Dukler Anti-Glycan Antibodies as Biomarkers for Diagnosis and Prognosis Lupus, July 1, 2006; 15(7): 442 - 450. [Abstract] [PDF]
|
|
|
|
 |
|
 S Marconi, M Acler, L Lovato, L De Toni, E Tedeschi, E Anghileri, S Romito, C Cordioli, and B Bonetti Anti-GD2-like IgM autoreactivity in multiple sclerosis patients Multiple Sclerosis, June 1, 2006; 12(3): 302 - 308. [Abstract] [PDF]
|
|
|
|
|
|
M Koga, S Koike, K Hirata, and N Yuki Ambiguous value of Haemophilus influenzae isolation in Guillain-Barre and Fisher syndromes J. Neurol. Neurosurg. Psychiatry, December 1, 2005; 76(12): 1736 - 1738. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Koga, M. Takahashi, M. Masuda, K. Hirata, and N. Yuki Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barre syndrome Neurology, November 8, 2005; 65(9): 1376 - 1381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Koga, M. Gilbert, J. Li, S. Koike, M. Takahashi, K. Furukawa, K. Hirata, and N. Yuki Antecedent infections in Fisher syndrome: A common pathogenesis of molecular mimicry Neurology, May 10, 2005; 64(9): 1605 - 1611. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Goodfellow, T. Bowes, K. Sheikh, M. Odaka, S. K. Halstead, P. D. Humphreys, E. R. Wagner, N. Yuki, K. Furukawa, K. Furukawa, et al. Overexpression of GD1a Ganglioside Sensitizes Motor Nerve Terminals to Anti-GD1a Antibody-Mediated Injury in a Model of Acute Motor Axonal Neuropathy J. Neurosci., February 16, 2005; 25(7): 1620 - 1628. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J-C Antoine, J-P Camdessanche, K Ferraud, and C Caudie Antiganglioside antibodies in paraneoplastic peripheral neuropathies J. Neurol. Neurosurg. Psychiatry, December 1, 2004; 75(12): 1765 - 1767. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Halstead, G. M. O'Hanlon, P. D. Humphreys, D. B. Morrison, B. P. Morgan, A. J. Todd, J. J. Plomp, and H. J. Willison Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy Brain, September 1, 2004; 127(9): 2109 - 2123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. C. Hughes, T. Umapathi, I. A. Gray, N. A. Gregson, M. Noori, A. S. Pannala, A. Proteggente, and A. V. Swan A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy Brain, August 1, 2004; 127(8): 1723 - 1730. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Attarian, J. -Ph. Azulay, B. Chabrol, N. Escande-Beillard, J. Pouget, and J. Boucraut Neonatal lower motor neuron syndrome associated with maternal neuropathy with anti-GM1 IgG Neurology, July 27, 2004; 63(2): 379 - 381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Zhang, P. H. H. Lopez, C. Y. Li, N. R. Mehta, J. W. Griffin, R. L. Schnaar, and K. A. Sheikh Anti-ganglioside antibody-mediated neuronal cytotoxicity and its protection by intravenous immunoglobulin: implications for immune neuropathies Brain, May 1, 2004; 127(5): 1085 - 1100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kaida, S. Kusunoki, M. Kanzaki, K. Kamakura, K. Motoyoshi, and I. Kanazawa Anti-GQ1b antibody as a factor predictive of mechanical ventilation in Guillain-Barre syndrome Neurology, March 9, 2004; 62(5): 821 - 824. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. Willison, K. Townson, J. Veitch, J. Boffey, N. Isaacs, S. M. Andersen, P. Zhang, C.-C. Ling, and D. R. Bundle Synthetic disialylgalactose immunoadsorbents deplete anti-GQ1b antibodies from autoimmune neuropathy sera Brain, March 1, 2004; 127(3): 680 - 691. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Siddiqui, E. Cahalane, M. Keogan, and O. Hardiman Chronic ataxic neuropathy with cold agglutinins: Atypical phenotype and response to anti-CD20 antibodies Neurology, November 11, 2003; 61(9): 1307 - 1308. [Full Text] [PDF]
|
|
|
|
|
|
G. M. O'Hanlon, P. D. Humphreys, R. S. Goldman, S. K. Halstead, R. W. M. Bullens, J. J. Plomp, Y. Ushkaryov, and H. J. Willison Calpain inhibitors protect against axonal degeneration in a model of anti-ganglioside antibody-mediated motor nerve terminal injury Brain, November 1, 2003; 126(11): 2497 - 2509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Capasso, C. M. Caporale, F. Pomilio, P. Gandolfi, A. Lugaresi, and A. Uncini Acute motor conduction block neuropathy Another Guillain-Barre syndrome variant Neurology, September 9, 2003; 61(5): 617 - 622. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. D M Hadden and R. A C Hughes MANAGEMENT OF INFLAMMATORY NEUROPATHIES J. Neurol. Neurosurg. Psychiatry, June 1, 2003; 74(90002): ii9 - 14. [Full Text] [PDF]
|
|
|
|
|
|
K. V. Toyka and R. Gold The pathogenesis of CIDP: Rationale for treatment with immunomodulatory agents Neurology, April 22, 2003; 60(90083): S2 - 7. [Abstract] [Full Text]
|
|